Results 21 to 30 of about 18,847 (260)
Bitemporal alopecia areata [PDF]
Australasian Journal of Dermatology, 2020 AbstractAlopecia areata has various clinical presentations, some of which have recognised prognostic significance. We report five cases of bitemporal alopecia areata, with involvement of the frontal hairline, the therapeutic approach for each case and possible differential diagnoses to also consider.
Nekma Meah +3 more
openaire +3 more sources
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder characterized by hair loss, for which there are few treatment options. This claims-based study characterized recent real-world treatment patterns among patients in the USA with alopecia areata, including the ...
Nicolae Done +6 more
doaj +1 more source
Acta Dermato-Venereologica, 2023 Alopecia areata is an autoimmune disorder that greatly impacts patients’ quality of life, and its management remains challenging. Tofacitinib is the first Janus kinase inhibitor to be approved for clinical use and is the most extensively studied. Several
Jundong Huang +5 more
doaj +1 more source
Acta Dermato-Venereologica, 2018 The development of androgenetic alopecia is associated with a risk of developing cardiovascular diseases, but the association of alopecia areata with cardiovascular diseases in humans is largely unexplored.
Eddy Hsi Wang +7 more
doaj +1 more source
SAGE Open Medical Case Reports, 2023 Alopecia areata is a non-scarring, autoimmune hair loss disorder that is associated with inflammatory bowel disease. Alopecia areata and inflammatory bowel disease may have a common pathogenic mechanism that involves the Janus kinase/STAT pathway.
Leah A Johnston +2 more
doaj +1 more source
Autoimmunity: Alopecia Areata [PDF]
Journal of Investigative Dermatology Symposium Proceedings, 2004 Strong direct and indirect evidence supports an autoimmune etiology for alopecia areata. T lymphocytes that have been shown to be oligoclonal and autoreactive are predominantly present in the peribulbar inflammatory infiltrate. Alopecia areata frequently occurs in association with other autoimmune diseases, such as thyroiditis and vitiligo, and ...
Hordinsky, Maria, Ericson, Marna
openaire +2 more sources
Allergology International, 2020 Background: The Japanese guidelines for the treatment of alopecia areata list topical immunotherapies as a drug therapy for this condition. However, there is insufficient evidence of its efficacy to support this recommendation. Thus, we sought to clarify
Keisuke Sakai +6 more
doaj +1 more source
Seminars in Cutaneous Medicine and Surgery, 2015 There is neither a cure for alopecia areata (AA) nor any universally proven therapy that induces and sustains remission in patients afflicted with this autoimmune disease. AA is characterized as a nonscarring alopecia which affects children and adults.
Maria, Hordinsky, Ana Lucia, Junqueira
openaire +2 more sources
SAGE Open Medical Case Reports, 2023 Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Selena Osman, Danya Traboulsi
doaj +1 more source
Acta Dermato-Venereologica, 2023 The aim of this study was to compare the efficacy and safety of treatment with Janus kinase inhibitors for alopecia areata, measured by change in Severity of Alopecia Tool (SALT) score.
Farnam Barati Sedeh +4 more
doaj +1 more source